The Australian Technical Advisory group on Immunisation(ATAGI) has reviewed their advice on AstraZeneca COVID-19 vaccine. The new advice, accepted by the Commonwealth Government, now recommends the Pfizer vaccine as the preferred vaccine for people aged under 60.
This recommendation is based on new evidence that has emerged that demonstrates a greater risk of Thrombosis with Thrombocytopenia Syndrome(TTS) in the 50-59 year old age group than initially thought. The incidence of TTS is significantly lower in people aged over 60 and the benefits of the vaccine still vastly outweigh any risk for people in this age group as they are much more likely to become seriously unwell if they catch COVID-19.
People who have had a first dose of the AstraZeneca vaccine and did not experience any serious adverse effects, will be offered a second AstraZeneca dose. The ATAGI advice remains unchanged that it is safe to have the second dose of AstraZeneca and that an alternative vaccine should not be used at this stage for the second dose if aged under 60.
COVID-19 Astra Zeneca Frequently Asked Questions-Updated 17 June 2021
How do the COVID 19 vaccines work?
How is a vaccine approved for use in Australia?
Were COVID-19 vaccines developed too quickly to be safe?
Are COVID-19 vaccines a bigger risk than contracting the virus?
Do people who have had COVID-19 and recovered need to get vaccinated?
Do COVID-19 vaccines contain a microchip or any kind of tracking technology?
Are COVID-19 vaccines not effective?
Do COVID-19 vaccines cause infertility?
Can COVID-19 vaccines alter my DNA?
Can COVID-19 vaccines give you COVID-19?
Does the Oxford/AstraZeneca vaccine contain animal DNA?
Do fit and healthy people have to get vaccinated?
How long does it take to have immunity after vaccination?
How long will the COVID-19 vaccine last once I have had two doses?
Will we need to get a COVID-19 booster shot each year?
Decision guide for people with immunocomprimise
Joint statement on AstraZeneca COVID-19 vaccine
ATAGI statement on a specific clotting condition being reported after COVID-19 vaccination
What to expect after your Astra Zeneca Covid 19 vaccine
AstraZeneca vaccine and thrombosis with thrombocytopenia syndrome
Weighing up the potential benefits against risk of harm from COVID-19 vaccine AstraZeneca
ATAGI revised recommendations on the use of COVID-19 Vaccine Astra Zeneca-17 June
COVID-19 Astra Zeneca Frequently Asked Questions-Updated 17 June 2021.
As a parent, your child’s health is one of your most important concerns. There a...
MoreWhether for business or pleasure, your travels will always be more enjoyable in ...
MoreWe are able to provide advice and management of a wide range of Women’s health i...
MoreWe offer same day appointments for existing patients with urgent matters. Blackw...
More